Transcriptional rate and steady‐state changes of retinoblastoma mRNA in regenerating rat liver

Betsy T. Kren, Amy L. Teel, Clifford J. Steer – 1 May 1994 – This study characterizes the mRNA expression of the retinoblastoma tumor suppressor gene in regenerating rat liver during 96 hr after 70% partial hepatectomy. A 960‐bp Bg1II‐OxaNI fragment of murine retinoblastoma cDNA was used to probe Northern blots of poly(A)+‐enriched RNA isolated from regenerating liver. Two species of retinoblastoma mRNA, 2.8 kb and 4.7 kb long, were identified in control liver and exhibited an intensity ratio of 5:1, respectively.

Rat liver epithelial cells: When it comes to differentiation, there's no place like home

Douglas C. Hixson, Ronald A. Faris – 1 May 1994 – Following intrahepatic transplantation in adult syngeneic Fischer 344 rats, diploid cultured rat liver epithelial cells (WB‐F344), modified to carry the Eschericia coli β‐galactosidase reporter gene and/or the fluorescent membrane dye PKH26‐GL, integrate into hepatic plates and acquire the size and nuclear structure of mature hepatocytes.

M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection

Akira Iizuka, Tatsuro Watanabe, Toshiyuki Kubo, Masahiro Yamamoto, Kazuo Ogawa, Tetsuo Ohkuma, Akira Kaji – 1 May 1994 – We investigated effects of various DNAs on duck hepatitis B virus replication in vivo. One‐day‐old ducks were infected intravenously with DHBV. Various DNAs were then injected intravenously, and duck hepatitis B virus levels were followed for up to 20 days after the inoculation.

The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

E. Jenny Heathcote, Karen Cauch‐Dudek, Valery Walker, Robert J. Bailey, Laurence M. Blendis, Cameron N. Ghent, Pina Michieletti, Gerald Y. Minuk, S. Chris Pappas, Linda J. Scully, Urs P. Steinbrecher, Lloyd R. Sutherland, C. Noel Williams, Helga Witt‐Sullivan, Lawrence J. Worobetz, Ruth A. Milner, Ian R. Wanless – 1 May 1994 – Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic.

Hepatic artery and portal vein vascularization of normal and cirrhotic rat liver

Ibrahim Kassissia, Antoine Brault, P.‐Michel Huet – 1 May 1994 – The hepatic artery and portal vein vascularization of seven normal and seven cirrhotic rats was evaluated by means of the multiple‐indicator dilution technique using the flow‐limited model analysis. Injected 15‐μm microspheres were all trapped by the liver in normal and cirrhotic rats after portal vein and hepatic artery injections, ruling out the presence of intrahepatic shunts larger than 15 μm.

SNOMED International (systematized nomenclature of human and veterinary medicine). 3rd ed. Edited by R.A. Cote, D.J. Rothwell, J.L. Palotay and R.S. Beckett. Vol. I (868 pp) and Vol. II (1160 pp), Numeric indices, Vol. III (1,004 pp) and Vol. IV (1,260 pp

Presinusoidal and proximal intrasinusoidal confluence of hepatic artery and portal vein in rat liver: Functional evidence by orthograde and retrograde bivascular perfusion

Yuji Watanabe, Gerhard P. Püschel, Andreas Gardemann, Kurt Jungermann – 1 May 1994 – The site of confluence of the artery and the portal vein in the liver still appears to be controversial. Anatomical studies suggested a presinusoidal or an intrasinusoidal confluence in the first, second or even final third of the sinusoids. The objective of this investigation was to study the problem with functional biochemical techniques.

Subscribe to